Sid Topiol

发表

The computational design of test compounds with potentially specific biological activity: Histamine-H2 agonists derived from 5-HT/H2 antagonists

Sid Topiol, Michael Sabio, M. Sabio, 1991, J. Comput. Aided Mol. Des..

RECOGNITION OF PROTEIN STRUCTURE: DETERMINING THE RELATIVE ENERGETIC CONTRIBUTIONS OF β-STRANDS, α-HELICES AND LOOPS

Boris A. Reva, Sid Topiol, 1999 .

The deletion model for the origin of receptors

Sid Topiol, S. Topiol, 1987 .

The role of experimental and computational structural approaches in 7TM drug discovery

Sid Topiol, Michael Sabio, M. Sabio, 2015, Expert opinion on drug discovery.

Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery.

Sid Topiol, Michael Sabio, M. Sabio, 2008, Bioorganic & medicinal chemistry letters.

Current and Future Challenges in GPCR Drug Discovery.

Sid Topiol, S. Topiol, 2018, Methods in molecular biology.

X-ray structure breakthroughs in the GPCR transmembrane region.

Sid Topiol, Michael Sabio, M. Sabio, 2009, Biochemical pharmacology.

X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?

Sid Topiol, S. Topiol, 2013, Expert opinion on drug discovery.

Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds.

Kenneth Jones, Sid Topiol, Michael Sabio, 2008, Bioorganic & medicinal chemistry letters.

Threading with chemostructural restrictions method for predicting fold and functionally significant residues: Application to dipeptidylpeptidase IV (DPP‐IV)

Alexei Finkelstein, Sid Topiol, A. Finkelstein, 2002, Proteins.

Electrostatic Potentials as Descriptors of Molecular Reactivity: The Basis for Some Successful Predictions of Biological Activity

Harel Weinstein, Roman Osman, Sid Topiol, 1981 .